Detection and interpretation of altered methylation patterns in cancer cells
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Epigenetic alterations, such as abnormal DNA-methylation patterns, are associated with many human tumour types. New techniques have been developed to perform genome-wide screening for alterations in DNA-methylation patterns, not only to identify tumour-suppressor genes, but also to find patterns that can be used in diagnosis and prognosis. However, interpretation of differential methylation has proven difficult because the significance of methylation alterations depends on the genomic region, and functions of CpG islands at specific sites have not been fully clarified. What techniques can be used to identify new tumour suppressors and diagnostic markers?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS influence the activity of epigenetic modulators, such as histone deacetylases (HDACs) or DNA methyltransferases (DNMTs) with consequences that are evident in the expression of the target genes38,39.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [39]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
Bell, A. C., & Felsenfeld, G. (2000) · Nature · doi:10.1038/35013100 · Cited by 1,746 · cited 1×
“), and defines regions for transcriptional regulatio”
Cited by
Items 101–200 of 482
Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers
Deng, D., Liu, Z., & Du, Y. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380864-6.00005-5 · Cited by 93
“The same situation may be also suitable to other genes (Deng et al., 2003b; Ushijima, 2005).”
BackgroundFrau, M., Tomasi, M. L., Simile, M. M., Demartis, M. I., Salis, F., Latte, G., Calvisi, D. F., Seddaiu, M. A., Daino, L., Feo, C. F., et al. (2012) · Hepatology · doi:10.1002/hep.25643 · Cited by 87
Self-citationSchmitt, A. M., Pavel, M. E., Rudolph, T. J., Dawson, H., Blank, A., Komminoth, P., Vassella, E., & Perren, A. A. (2014) · Neuroendocrinology · doi:10.1159/000365514 · Cited by 86
Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing
Shi, J., Zhang, R., Li, J., & Zhang, R. (2020) · Theranostics · doi:10.7150/thno.42565 · Cited by 96
“Genome-wide hypomethylation is frequently observed in tumors, such as breast, hepatocellular carcinoma, nasopharyngeal, neuroendocrine, and lung tumors [41-43].”
BackgroundGene methylation and early detection of genitourinary cancer: the road ahead
Cairns, P. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2170 · Cited by 84
Alterations of DNA methylation and clinicopathological diversity of human cancers
Kanai, Y. (2008) · Pathology International · doi:10.1111/j.1440-1827.2008.02270.x · Cited by 81
Downregulation and growth inhibitory role of FHL1 in lung cancer
Niu, C., Liang, C., Guo, J., Cheng, L., Zhang, H., Qin, X., Zhang, Q., Ding, L., Yuan, B., Xu, X., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26259 · Cited by 81
“Methylation of CpG-rich promoter regions of genes, an epigenetic phenomenon that is often associated with the transcriptional silencing of genes, is common in cancer cells.(34) The hypermetylation of CpG islands within FHL1 gene promoter regions has been reported in bladder cancer.”
BackgroundPotential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Tang, M., Xu, W., Wang, Q., Xiao, W., & Xu, R. (2009) · Current Genomics · doi:10.2174/138920209788920994 · Cited by 80
“Accumulating investigations have demonstrated that lung cancer development is linked with aberrant DNA methylation patterns, which can be characterized as global genome hypomethylation accompanied by regional hypermethylation [16-18].”
BackgroundRole of PCDH10 and its hypermethylation in human gastric cancer
Li, Z., Chim, J. C. S., Yang, M., Ye, J., Yu, W. B. C., & Qiao, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.011 · Cited by 80
“Recent studies have showed that PCDH10 is down-regulated and hypermethylated in many human cancers including breast cancer, nasopharyngeal cancer, esophageal cancer, and some haematologic malignancies [4,19,20].”
BackgroundOxidative stress-mediated biomolecular damage and inflammation in tumorigenesis.
Sesti, F., Tsitsilonis, O., Kotsinas, A., & Trougakos, I. P. (2012) · PubMed · Cited by 94
Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes
Kaneda, A., & Yagi, K. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01712.x · Cited by 87
der Auwera, I. V., Laere, S. V., van den Bosch, S. M., den Eynden, G. G. V., Trinh, B., van Dam, P. A., Colpaert, C., van Engeland, M., Marck, E. A. V., Vermeulen, P., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604705 · Cited by 80
Takada, H., Wakabayashi, N., Dohi, O., Yasui, K., Sakakura, C., Mitsufuji, S., Taniwaki, M., & Yoshikawa, T. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.11.004 · Cited by 76
“004 aberrations [11].”
Katsurano, M., Niwa, T., Yasui, Y., Shigematsu, Y., Yamashita, S., Takeshima, H., Lee, M. S., Kim, Y., Tanaka, T., & Ushijima, T. (2011) · Oncogene · doi:10.1038/onc.2011.241 · Cited by 81
“Especially, DNA methylation is stably inherited upon somatic cell replication (Riggs and Xiong, 2004) and methylation of promoter CpG islands (CGIs) consistently inactivates their downstream genes, including tumor-suppressor genes, such as CDK2A, HIC1 and SOCS1 (Ushijima, 2005).”
BackgroundSelf-citationChoy, L. Y. L., Peng, W., Jiang, P., Cheng, S. H., Yu, S. C. Y., Shang, H., Tse, O. Y. O., Wong, J., Wong, V. W., Wong, G. L., et al. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac086 · Cited by 74
A personalized view on cancer immunotherapy
Wayteck, L., Breckpot, K., Demeester, J., Smedt, S. C. D., & Raemdonck, K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.016 · Cited by 94
“In particular, expression of CTA is switched on by demethylation of the promotor region of the CTA encoding gene [42].”
BackgroundDeng, G., Nguyen, A., Tanaka, H., Matsuzaki, K., Bell, I., Mehta, K. R., Terdiman, J. P., Waldman, F. M., Kakar, S., Gum, J., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21740 · Cited by 74
Balassiano, K. Z., Soares‐Lima, S. C., Jenab, M., Overvad, K., Tjønneland, A. M., Boutron‐Ruault, M., Clavel‐Chapelon, F., Canzian, F., Kaaks, R., Boeing, H., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.038 · Cited by 79
“Our results also revealed that methylation levels across CpG sites of any of the genes analyzed in tumor and blood samples do not show an appreciable difference, consistent with the previous reports showing that methylation states within a given CpG island tend to be homogeneous and usually do not vary significantly a…”
ResultThe Role of DNA Methylation in Renal Cell Carcinoma
Lasseigne, B. N., & Brooks, J. D. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0337-9 · Cited by 75
Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Smith, C., Bolton, A., & Nguyen, G. (2010) · Current Genomics · doi:10.2174/138920210793176001 · Cited by 73
“The number and location of methylated CpG sites in promoter regions usually, but not always, correlates with gene expression in vivo [24, 25, 36, 37, 38, 42].”
BackgroundAccumulation of aberrant DNA methylation during colorectal cancer development
Sakai, E., Nakajima, A., & Kaneda, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i4.978 · Cited by 86
Cancer Stem Cells: Biological Functions and Therapeutically Targeting
Ciurea, M. E., Georgescu, A., Purcaru, Ş. O., Artene, Ş.-A., Emami, G., Boldeanu, M. V., Tache, D. E., & Dricu, A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058169 · Cited by 76
“The CSC hypothesis gained credibility because all main cancer-origin theories (genetic/epigenetic events, chemical-, infection-, virus-induced carcinogenesis) indicated that the tissue stem cell is involved in the generation of cancer [2,38–43].”
BackgroundYang, P., Ma, J., Zhang, B., Duan, H., He, Z., Zeng, J.-L., Zeng, X., Li, D., Wang, Q., Xiao, Y., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0784 · Cited by 79
“CpG islands were located in different regions of genes (53), and differential methylation can be observed in any region of these CpG islands (54).”
BackgroundDNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations
Gaudet, M. M., Campan, M., Figueroa, J. D., Yang, X. R., Lissowska, J., Pepłońska, B., Brinton, L. A., Rimm, D. L., Laird, P. W., García‐Closas, M., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0678 · Cited by 83
“However, methylation patterns in cell lines and human breast tumors may differ (11).”
BackgroundInfluentialDNA Methylation Modulates Nociceptive Sensitization after Incision
Sun, Y., Sahbaie, P., Liang, D., Li, W., Shi, X., Kingery, P., & Clark, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142046 · Cited by 68
“DNA methylation is a covalent modification and involves the transfer of a methyl group to cysteine residues at CpG sites, which are 5'-CG-3' dinucleotide sequences in the genome, and clusters of CpG sites known as CpG islands, which are often in the promoter regions of genes [4].”
BackgroundGenetically informed lung cancer medicine
Pao, W., Iafrate, A. J., & Su, Z. (2011) · The Journal of Pathology · doi:10.1002/path.2788 · Cited by 66
“Besides DNA mutations, other alterations may also play a role in tumour sensitivity, such as DNA methylation [103,104] and loss of tumour suppressor genes [105].”
BackgroundThe epigenome of testicular germ cell tumors
Lind, G. E., Skotheim, R. I., & Lothe, R. A. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_660.xml.x · Cited by 69
Blood-based DNA methylation signatures in cancer: A systematic review
Li, Y., Fan, Z., Meng, Y., Liu, S., & Zhan, H. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166583 · Cited by 78
Compendium of aberrant DNA methylation and histone modifications in cancer
Hattori, N., & Ushijima, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.140 · Cited by 77
“Therefore, regional hypermethylation in a promoter CGI of a tumor-suppressor gene can inactivate the gene, leading to tumor development and tumor progression [8].”
Self-citationThe role of epigenetics in environmental and occupational carcinogenesis
Ziech, D., Franco, R., Pappa, A., Malamou‐Mitsi, V., Georgakila, S., Georgakilas, A. G., & Panayiotidis, M. I. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.06.012 · Cited by 68
Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples
Varley, K. E., & Mitra, R. D. (2010) · Genome Research · doi:10.1101/gr.101212.109 · Cited by 66
“Many techniques have been developed to detect DNA methylation, including methods based on microarrays (Ushijima 2005), quantitative PCR (Eads et al.”
MethodNagasaka, T., Goel, A., Notohara, K., 高畑, 隆., Sasamoto, H., Uchida, T., Nishida, N., Tanaka, N., Boland, C. R., & Matsubara, N. (2008) · International Journal of Cancer · doi:10.1002/ijc.23398 · Cited by 65
“0013 Wild-type (n 5 157) 46 (26) 70 (19) 75 (112) AP Mutations (n5 21) G to A (n5 14) 25 (1) 17 (5) 11 (8) Others (n 5 7) 0 (0) 10 (3) 6 (4) 0.”
Shin, C. M., Kim, N., Jung, Y., Park, J. H., Kang, G. H., Kim, J. S., Jung, H. C., & Song, I. S. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01535.x · Cited by 69
Alu and Satα hypomethylation in Helicobacter pylori‐infected gastric mucosae
Yoshida, T., Yamashita, S., Takamura‐Enya, T., Niwa, T., Ando, T., Enomoto, S., Maekita, T., Nakazawa, K., Tatematsu, M., Ichinose, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25534 · Cited by 66
“On the other hand, hypermethylation is observed in normally unmethylated promoter CpG islands and silences downstream genes, including tumor suppressor and other passenger genes.(11) Hypermethylation of CpG islands can be present not only in cancers but also in noncancerous tissues.”
BackgroundSelf-citationLi, K., Yang, J., & Han, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223519 · Cited by 70
“growth, metastasis, reduced apoptosis or maintainence of angiogenesis, all of which promote tumor development [17,19].”
BackgroundApplying whole-genome studies of epigenetic regulation to study human disease
Lieb, J. D., Beck, S., Bulyk, M. L., Farnham, P., Hattori, N., Henikoff, S., Liu, X. S., Okumura, K., Shiota, K., Ushijima, T., et al. (2006) · Cytogenetic and Genome Research · doi:10.1159/000091922 · Cited by 74
“Most of the techniques used to date have been reviewed comprehensively (Laird, 2003; Ushijima, 2005), although several recent publications update this list (Ching et al.”
InfluentialSelf-citationQuantitative hypermethylation of NMDAR2B in human gastric cancer
Liu, J., Kim, M. S., Nagpal, J. K., Yamashita, K., Poeta, M. L., Chang, X., Lee, J., Park, H. L., Jerónimo, C., Westra, W. H., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22934 · Cited by 65
“Many tumor cells retain a different methylation pattern in gene promoters when compared with normal cells.(6)”
BackgroundKim, J. W., Kim, S., Turner, A. R., Young, T., Smith, S. G., Liu, W., Lindberg, J., Egevad, L., Grönberg, H., Isaacs, W. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048455 · Cited by 63
“Using this method, it may difficult to identify core methylated regions that are critical for regulating gene expression; therefore an additional assay is required for precise assessment of DNA methylation at individual CpG sites [21].”
MethodMisawa, A., Inoue, J., Sugino, Y., Hosoi, H., Sugimoto, T., Hosoda, F., Ohki, M., Imoto, I., & Inazawa, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1073 · Cited by 64
“Although several techniques, including a method known as methylated CpG island amplification (MCA), have been developed (10, 11), we still have limited number of effective and practical high-throughput methods for genomewide screening of aberrantly methylated CpG-rich sequences.”
MethodAberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour
Okamoto, Y., Sawaki, A., Ito, S., Nishida, T., Takahashi, T., Toyota, M., Suzuki, H., Shinomura, Y., Takeuchi, I., Shinjo, K., et al. (2011) · Gut · doi:10.1136/gut.2011.241034 · Cited by 66
“Identification of prognostic markers in GIST DNA methylation has been proposed as a diagnostic and/or prognostic marker for malignancies.(14) We next investigated whether DNA methylation status could be a prognostic marker for GIST.”
BackgroundSilencing of tissue factor pathway inhibitor‐2 gene in malignant melanomas
Nobeyama, Y., Okochi‐Takada, E., Furuta, J., Miyagi, Y., Kikuchi, K., Yamamoto, A., Nakanishi, Y., Nakagawa, H., & Ushijima, T. (2007) · International Journal of Cancer · doi:10.1002/ijc.22637 · Cited by 62
“Genome-wide screening for aberrant methylation is useful to identify genes with epigenetic aberrations, and various techniques have been developed.(15) Most techniques are based on the methylation status of genomic DNA, including methylation-sensitive-representational difference analysis (MS-RDA) and restriction landm…”
BackgroundMethodInfluentialSelf-citationThe Translational Status of Cancer Liquid Biopsies
Bratulić, S., Gatto, F., & Nielsen, J. (2019) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-019-00141-2 · Cited by 70
“Changes in epigenomic regulators during tumorigenesis in turn lead to changes in methylation patterns compared to normal cells [125, 126].”
BackgroundInfluentialCpG islands: their potential as biomarkers for cancer
Shi, H., Wang, M., & Caldwell, C. W. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.5.519 · Cited by 71
Kim, Y., Yoon, H. Y., Kim, Y.-W., Kim, E., Kim, W., Kim, I. Y., & Kim, W. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2817 · Cited by 66
“However, to identify bona fide candidate methylation markers, rigorous selection criteria, confirmation of methylation status and expression level, verification of reexpression upon exposure to demethylating agents, and validation in human tissues aremandatory (10).”
BackgroundBreast cancer prognostication and prediction in the postgenomic era
Lønning, P. E., Knappskog, S., Staalesen, V., Chrisanthar, R., & Lillehaug, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm013 · Cited by 72
“Basically, two main mechanisms; promoter hypermethylations [134] and histone deacetylations [135], have been discovered (Figure 2).”
BackgroundDNA methylation and cancer: ghosts and angels above the genes
Sinčić, N., & Herceg, Z. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283412eb4 · Cited by 73
Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations
Verma, M., & Manne, U. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.04.002 · Cited by 70
Vineis, P., Chuang, S., Vaissière, T., Cuenin, C., Ricceri, F., collaborators, G. E., Johansson, M., Ueland, P. M., Brennan, P., & Herceg, Z. (2011) · Epigenetics · doi:10.4161/epi.6.2.13573 · Cited by 71
“In order to investigate the methylation level of several genes, targeted sequences were localized in bona fide CpG islands.(17,18) For each gene, sets of primers were designed on an in silico modified DNA sequence (Sup.”
MethodMiyata, Y., Matsuo, T., Sagara, Y., Ohba, K., Ohyama, K., & Sakai, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102214 · Cited by 64
“For example, H2O2 has been reported to hypermethylate tumor-suppressor genes, such as retinoblastoma, Von Hippel–Lindau, and breast cancer 1 [13,14].”
BackgroundCai, L., Abe, M., Izumi, S., Imura, M., Yasugi, T., & Ushijima, T. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.015 · Cited by 60
Self-citationShin, S., Park, S.-Y., & Kang, G. H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.004 · Cited by 66
Single-Tube Analysis of DNA Methylation with Silica Superparamagnetic Beads
Bailey, V. J., Zhang, Y., Keeley, B. P., Yin, C., Pelosky, K. L., Brock, M. V., Baylin, S. B., Herman, J. G., & Wang, T. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.140244 · Cited by 61
Kuchiba, A., Iwasaki, M., Ono, H., Kasuga, Y., Yokoyama, S., Onuma, H., Nishimura, H., Kusama, R., Tsugane, S., & Yoshida, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.223 · Cited by 58
“…is clearly observed in multiple distinct genomic regions harbouring tumour-suppressor and mutator genes regulating their transcriptional activities (Ushijima, 2005), global hypomethylation is known to cause genomic instability, reactivation of transposable elements, and loss of imprinting, thereby…”
BackgroundLong interspersed nucleotide element-1 (LINE-1) methylation in colorectal cancer
Kerachian, M. A., & Kerachian, M. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.11.018 · Cited by 62
Feng, Q., Qin, L., Wang, M., & Wang, P. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111847 · Cited by 57
Aberrant Gene Silencing in Tumor Progression: Implications for Control of Cancer
Baylin, S. B., & Chen, W. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.010 · Cited by 63
“…and early diagnosis. matin events mediating transcriptional repression are pharmacologically reversed (Akama et al. 1997; Huang et al. 1999; Toyota et al. 1999; Costello et al. 2000; Salem et al. 2000; Suzuki et al. 2002; Yamashita et al. 2002; Shi et al. 2003; Ushijima 2005; Yu et al. 2005).”
BackgroundWang, P., Chen, H., Tian, J., Dai, Z., & Zou, X. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.01.057 · Cited by 57
“…(5-mC) is an important modified pyrimidine base containing heritable information (Kato et al., 2008a; Kurita et al., 2012; Kurita and Niwa, 2012), which is often associated with transcriptional silence of tumor suppressor genes (Ushijima, 2005; Choy et al., 2010; Cao and Zhang, 2012).”
BackgroundDNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae
Yamashita, M., Toyota, M., Suzuki, H., Nojima, M., Yamamoto, E., Kamimae, S., Watanabe, Y., Kai, M., Akashi, H., Maruyama, R., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01581.x · Cited by 62
DNA Demethylating Agents and Epigenetic Therapy of Cancer
Mani, S., & Herceg, Z. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60012-5 · Cited by 60
Park, J. K., Ryu, J. K., Yoon, W. J., Lee, S. H., Lee, G. Y., Jeong, K.-S., Kim, Y., & Yoon, Y. B. (2011) · Pancreas · doi:10.1097/mpa.0b013e318221c903 · Cited by 55
“The aberrant DNAmethylation involves promoter CpG island methylation and silences genes.(23,24) Furthermore, it also has been reported that abnormally high DNA concentrations can be also detected in serum, plasma, and urine of cancer patients.”
BackgroundAbe, M., Westermann, F., Nakagawara, A., Takato, T., Schwab, M., & Ushijima, T. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.05.001 · Cited by 55
“It is known that exonic CGIs aremore susceptible tomethylation than promoter CGIs [9], and it is expected that they are more useful as a prognostic marker.”
BackgroundMethodSelf-citationIGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer
Pérez–Carbonell, L., Balaguer, F., Toiyama, Y., Egoavil, C. M., Rojas, E., Guarinós, C., Andreu, M. G., Llor, X., Castells, A., Jover, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104285 · Cited by 57
“Aberrant DNA methylation represents one of the most studied epigenetic alteration, and it is well understood that tumor suppressor genes are frequently silenced by methylation of CpG islands which commonly reside in the 59 regions of approximately half of all human genes [2,3,4].”
BackgroundWang, Y., Fu, J., Jiang, M., Zhang, X., Cheng, L., Xu, X., Fan, Z., Zhang, J., Ye, Q., & Song, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108708 · Cited by 55
“The inactivation of tumor-suppressor genes is a characteristic step in cancer development and progression [1].”
DNA methylation: a marker for carcinogen exposure and cancer risk
Nakajima, T., Enomoto, S., & Ushijima, T. (2007) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-007-0005-x · Cited by 54
“Since low transcription levels are known to trigger promoter methylation [12, 29], it was concluded that H.”
BackgroundSelf-citationAn overview of epigenetics and chemoprevention
Huang, Y., Kuo, C.-T., Stoner, K., Huang, T. H. ‐., & Wang, L.-S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.11.002 · Cited by 58
“Summarizing results from studies on the correlation between the position of the methylation within a given gene and gene expression indicates that methylation degree within and/or around the promoter region is negatively associated with gene expression level [7,8].”
Background5-hydroxymethylcytosine: A new insight into epigenetics in cancer
Ye, C., & Li, L. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.27144 · Cited by 63
Oishi, Y., Watanabe, Y., Yoshida, Y., Sato, Y., Hiraishi, T., Oikawa, R., Maehata, T., Suzuki, H., Toyota, M., Niwa, H., et al. (2011) · Tumor Biology · doi:10.1007/s13277-011-0278-y · Cited by 52
Somatic evolution of cancer cells
Boland, C. R., & Goel, A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.001 · Cited by 62
Enokida (2009) · International Journal of Oncology · doi:10.3892/ijo_00000289 · Cited by 52
“Recent intensive study of the epigenetic change of gene promoter hypermethylation has shown that it is an important molecular mechanism contributing to tumor suppressor gene inactivation in human cancer (3).”
BackgroundEpigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer
Park, S., Jang, H.-R., Kim, S., Kim, J., Kwon, O.-H., Park, J., Noh, S., Song, K. S., Kim, S., Kim, Y. H., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs178 · Cited by 51
Sarabi, M. M., & Naghibalhossaini, F. (2015) · Cell Biochemistry and Function · doi:10.1002/cbf.3126 · Cited by 53
An, J., Pan, Y., Yan, Z. P., Li, W., Cui, J., Yuan, J., Tian, L., Xing, R., & Lu, Y. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24565 · Cited by 52
“Chromosomal instability is a characteristic of cancer [Ushijima, 2005] including GC [Vauhkonen et al., 2006; Yang et al., 2007].”
BackgroundWang, P., Wu, H. Y., Dai, Z., & Zou, X. (2012) · Chemical Communications · doi:10.1039/c2cc35615e · Cited by 51
Abe, M., Watanabe, N., McDonell, N., Takato, T., Ohira, M., Nakagawara, A., & Ushijima, T. (2008) · Oncology · doi:10.1159/000139124 · Cited by 57
Self-citationGoto, K., Kato, D., Sekioka, N., Ueda, A., Hirono, S., & Niwa, O. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.06.004 · Cited by 51
Asada, K., Ando, T., Niwa, T., Nanjo, S., Watanabe, N., Okochi‐Takada, E., Yoshida, T., Miyamoto, K., Enomoto, S., Ichinose, M., et al. (2012) · Oncogene · doi:10.1038/onc.2012.228 · Cited by 51
Self-citationMa, S., Sun, H., Li, Y., Qi, H., & Zheng, J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b01265 · Cited by 51
Yamaguchi, S., Asanoma, K., Takao, T., Kato, K., & Wake, N. (2008) · International Journal of Cancer · doi:10.1002/ijc.24217 · Cited by 51
“Even though there is an overall decrease in DNA methylation during carcinogenesis, particular CpG island sequences are hypermethylated resulting in the transcriptional silencing of critical genes and contributing to development and progression of a variety of human cancers.(1,2)”
BackgroundQuantitative analysis of human tissue-specific differences in methylation
Igarashi, J., Muroi, S., Kawashima, H., Wang, X., Shinojima, Y., Kitamura, E., Oinuma, T., Nemoto, N., Song, F., Ghosh, S., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.044 · Cited by 53
Zerbini, L. F., & Libermann, T. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1475 · Cited by 50
Wang, L.-S., Kuo, C.-T., Stoner, K., Yearsley, M., Oshima, K., Yu, J., Huang, T. H. ‐., Rosenberg, D. W., Peiffer, D., Stoner, G. D., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt310 · Cited by 50
Vinci, S., Giannarini, G., Selli, C., Kuncová, J., Villari, D., Valent, F., & Orlando, C. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.003 · Cited by 49
Imura, M., Yamashita, S., Cai, L., Furuta, J., Wakabayashi, M., Yasugi, T., & Ushijima, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.10.010 · Cited by 48
Self-citationMethylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer
Murata, A., Baba, Y., Watanabe, M., Shigaki, H., Miyake, K., Ishimoto, T., Iwatsuki, M., Iwagami, S., Sakamoto, Y., Miyamoto, Y., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.289 · Cited by 50
“Along with genetic mutations, epigenetic changes such as DNA methylation and histone modification are important for carcinogenesis and tumour development (Issa, 2004; Ushijima, 2005; Esteller, 2006).”
BackgroundEpigenetic inactivation of ST6GAL1 in human bladder cancer
Antony, P., Rose, M., Heidenreich, A., Knüchel, R., Gaisa, N. T., & Dahl, E. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-901 · Cited by 47
“It is well known that epigenetic alterations, such as DNA methylation, are common mechanisms contributing to tumorigenesis and tumor progression [29,31,32].”
BackgroundGenetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway
Sakai, E., Fukuyo, M., Ohata, K., Matsusaka, K., Doi, N., Mano, Y., Takane, K., Abé, H., Yagi, K., Matsuhashi, N., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29903 · Cited by 46
Hammerling, U., Laurila, J. B., Grafström, R., & Ilbäck, N. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.972498 · Cited by 58
“Moreover, promoter hypermethylation is a major inactivation route for tumor suppressor genes in malignant diseases, thereby leading to (or contributing to) tumor initiation or progression (Ushijima, 2005).”
BackgroundLi, L., Ying, J., Tong, X., Zhong, L., Su, X., Xiang, T., Shu, X., Rong, R., Xiong, L., Li, H., et al. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1485-z · Cited by 50
Kim, S., Lee, K., Jang, H.-R., Kim, J.-H., Noh, S., Song, K., Cho, J.-S., Jeong, H. Y., Kim, S., Yoo, H., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0142 · Cited by 46
“genesis inhibitors, and other genes involved in tumor progression (2, 3).”
BackgroundDynamic changes of DNA epigenetic marks in mouse oocytes during natural and accelerated aging
Qian, Y., Tu, J., Tang, N. L. S., Kong, G. W. S., Chung, J. P. W., Chan, W., & Lee, T. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.005 · Cited by 46
Stress-induced depressive behaviors are correlated with Par-4 and DRD2 expression in rat striatum
Zhu, X., Peng, S., Zhang, S., & Zhang, X. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.052 · Cited by 45
Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer
Liu, J., Nagpal, J. K., Jerónimo, C., Lee, J., Henrique, R., Kim, M. S., Ostrow, K. L., Yamashita, K., Criekinge, W. V., Wu, G., et al. (2008) · The Prostate · doi:10.1002/pros.20709 · Cited by 43
“Thus far, more than 30 genes have been reported as methylated in prostate cancer, many with little knowledge of their biological function [5].”
BackgroundInfluentialPreliminary Study Analyzing the Methylated Genes in the Plasma of Patients with Pancreatic Cancer
Park, J. W., Baek, I. H., & Kim, Y. T. (2012) · Scandinavian Journal of Surgery · doi:10.1177/145749691210100108 · Cited by 44
Methylation Silencing of Transforming Growth Factor-β Receptor Type II in Rat Prostate Cancers
Yamashita, S., Takahashi, S., McDonell, N., Watanabe, N., Niwa, T., Hosoya, K., Tsujino, Y., Shirai, T., & Ushijima, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5282 · Cited by 43
“To identify methylation-silenced genes in rat prostate cancers, a chemical genomic screening method (2) was adopted for its efficiency.”
BackgroundMethodSelf-citationSleeping beauty: a novel cancer gene discovery tool
Dupuy, A. J., Jenkins, N. A., & Copeland, N. G. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl061 · Cited by 43
“Overlapping but distinct sets of genes seem to be targeted by genetic and epigenetic alterations in cancer (5).”
BackgroundMethylation of the SPARC gene promoter and its clinical implication in pancreatic cancer
Gao, J., Song, J., Huang, H., Li, Z., Du, Y., Cao, J., Li, M., Lv, S., Han, L., & Gong, Y.-F. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-28 · Cited by 42
“Among these alterations, methylation of the tumor suppressor gene promoter results in gene silencing [6], which may take place during the very early stages of pancreatic cancer development.”
BackgroundSakamoto, H., Suzuki, M., Abe, T., Hosoyama, T., Himeno, E., Tanaka, S., Greally, J. M., Hattori, N., Yagi, S., & Shiota, K. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01120.x · Cited by 44
Li, Z., Zhang, G., Li, D., Jie, Z., Chen, H., Xiong, J., Liu, Y., Cao, Y., Jiang, M., Le, Z., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.083 · Cited by 41
“The human GC cell lines SGC7901, MKN45, MKN28, and BGC823 were purchased from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China).”
BackgroundMethodInfluentialHypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer.
Chen, L., Su, L., Li, J., Zheng, Y., Yu, B., Yu, Y., Yan, M., Gu, Q., Zhu, Z., & Liu, B. (2012) · PubMed Central · doi:10.3233/dma-2011-0877 · Cited by 41
“Several studies have addressed the diagnostic utility of epigenetic biomarkers in the detection of human cancer [10].”
BackgroundHosoya, K., Yamashita, S., Ando, T., Nakajima, T., Itoh, F., & Ushijima, T. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.016 · Cited by 43
“DNA methylation of the nucleosome-free region immediately upstream of a TSS is critical for gene silencing, and accurate determination of TSSs is important to evaluate involvement of DNA methylation in gene silencing [1,2,27].”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Ushijima, T.
- Affiliations
- National Cancer Center Research Institute (JP)
- Corresponding author
- Ushijima, Toshikazu
- ORCID
- Ushijima, Toshikazu
- Venue
- Nature Reviews Cancer
- Published
- 2005-02-18
- Volume
- 5
- Issue
- 3
- Pages
- 223-231
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1999464755
- Cited by
- 483
- References
- 90
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 13 · 2022: 13 · 2021: 4 · 2020: 17 · 2019: 17 · 2018: 9 · 2017: 12 · 2016: 15 · 2015: 25 · 2014: 26 · 2013: 36 · 2012: 30
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- DNA methylation, epigenetic modifications, cancer, tumor suppressor, diagnostic biomarkers, prognostic factors, CpG islands
- MeSH terms
- DNA, Neoplasm, Genetic Markers, Humans, Neoplasms, Promoter Regions, Genetic, Genes, Tumor Suppressor, Genome, CpG Islands, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.